Psychiatry & Neurology Doctors in Grand Junction, CO Accepting Medicare

27 Psychiatry & Neurology doctors found. Showing 21 - 27

Gloria Gage, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-242-0731

Neal J Gilman, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 341 Quail Dr, Grand Junction, CO 81507 Phone: 970-242-1525

Dolores D Tiongco, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 541 Hoover Dr, Grand Junction, CO 81504 Phone: 970-256-0066

Dr. Patricia Gallagher Lapkin, MD Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 515 28 3/4 Rd, Grand Junction, CO 81501 Phone: 970-241-6023    Fax: 970-242-8330

Mark D Ramsey, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 515 28 3/4 Rd, Grand Junction, CO 81501 Phone: 970-263-4918    Fax: 970-683-7279

Ms. Nicole Jeannelle Montgomery, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-263-2824    Fax: 970-263-2819

Roger E Jacobson, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 2121 North Ave, Grand Junction, CO 81501 Phone: 970-263-2824

News Archive

Omega Healthcare Investors reports $21.0 million net income for first-quarter 2010

Omega Healthcare Investors, Inc. today announced its results of operations for the quarter ended March 31, 2010. The Company also reported Funds From Operations ("FFO") available to common stockholders for the three months ended March 31, 2010 of $33.4 million or $0.38 per common share.

AgeneBio receives grant to develop neural stabilizer therapy for amnestic mild cognitive impairment

The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.

Study links inherited variations in few genes to increased risk of pediatric leukemia

Humans have between 20,000 and 25,000 genes that carry instructions for assembling the proteins that do the work of cells. Work led by St. Jude Children's Research Hospital found that children who inherit certain variations in four particular genes are at much higher risk of developing acute lymphoblastic leukemia.

Potential new target for drugs to prevent HIV-associated dementia

A new study led by researchers at Albert Einstein College of Medicine of Yeshiva University has clarified how two major variants of HIV differ in their ability to cause neurologic complications.

Perrigo files ANDA and confirms Astepro Nasal Spray patent challenge

Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.

Read more Medical News

› Verified 2 days ago

• 1
• 2(current)